|  | | Related Knowledge Base Chapters | | |
| Journal Articles | |  | Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community
Middelkoop K, Bekker LG, Myer L, Johnson LF, Kloos M, Morrow C, Wood R. J Acquir Immune Defic Syndr. 2011 56:3, 263-269. Includes commentary from the UCSF Institute for Global Health. | | | | Impact of tuberculosis cotreatment on viral suppression rates among HIV-positive children initiating HAART
Zanoni BC, Phungula T, Zanoni HM, France H, Feeney ME. AIDS. 2011, Jan 2;25(1):49-55. Includes commentary from the UCSF Institute for Global Health. | | | | Clinical deterioration during anti-tuberculosis treatment in Africa: Incidence, causes and risk factors
Pepper DJ, Marais S, Wilkinson RJ, et al. BMC Infect Dis. 2010 Mar 30;10:83. Includes commentary from the UCSF Institute for Global Health. | | | | Mycobacterium tuberculosis microbiologic and clinical treatment outcomes in a randomized controlled trial of immediate versus CD4+-initiated antiretroviral therapy in HIV-infected adults with a high CD4+ cell count
Chamie G, Charlebois ED, Srikantish P, et al. Clin Infect Dis. 2010; 51: 359-62. Includes commentary from the UCSF Institute for Global Health. | | | | Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa
Lawn SD, Myer L, Edwards D, et al. AIDS. 2009 Aug 24;23(13):1717-25. Includes commentary from the UCSF Institute for Global Health. | | | | Intensified tuberculosis case finding among HIV-infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia
Shah S, Demissie M, Lambert L, et al. J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):537-45. Includes commentary from the UCSF Institute for Global Health. | | | | Successful integration of tuberculosis and HIV treatment in rural South Africa: The Sizonq'oba Study
Gandhi N, Moll A, Lalloo U, et al. JAIDS. 2009 Jan;50(1):37-43. Includes commentary from the UCSF Institute for Global Health. | | | | Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy
Westreich DJ, Sanne I, Maskew M, et al. Clin Infect Dis. 2009 Jun 1;48(11):1617-23. | | | | Paradigm shift to address drug resistant tuberculosis in people living with HIV needed, and needed now
Getahun H, Havlir D, Granich R, Reid A, Jaramillo E, Nunn P. Tropical Medicine & International Health. 2009 Apr;14(4):376 - 378. | | | | The infectiousness of tuberculosis patients coinfected with HIV
Escombe AR, Moore DA, Gilman RH, et al. PLoS Med. 2008 Sep 30;5(9):e188. | | | | Effects of duration of HIV infection and secondary tuberculosis transmission on tuberculosis incidence in the South African gold mines
Glynn J, Murray J, Bester A, Nelson G, Shearer S, Sonnenberg P. AIDS. 2008;22:1859-67. Includes commentary from the UCSF Institute for Global Health. | | | | Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens.
Mak A, Thomas A, Del Granado M, et al. Am J Respir Crit Care Med. 2008 Aug 1;178(3):306-12. | | | | Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis.
Lew W, Pai M, Oxlade O, Martin D, et al. Ann Intern Med. 2008 Jul 15;149(2):123-34. | | | | Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa
Manormoney P, Sturm AW. Clinical Infectious Diseases 2007;45:1409-1414. | | | | Extensively drug-resistant Mycobacterium tuberculosis: Charles Darwin would understand
Iseman MD. Clinical Infectious Diseases 2007;45:1415-1416. | | | | Tuberculosis and HIV coinfection: current state of knowledge and research priorities
Friedland G, Churchyard GJ, Nardell E. J Infect Dis. 2007 Aug 15;196 Suppl 1:S1-3. | |
| |
| Guidelines and Best Practices | | | Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis
Centers for Disease Control and Prevention, MMWR. 2009 Jan 16;58 (01); 7-10. | | | | Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents
Recommendations of the CDC, the National Institutes of Health, and the Infectious Diseases Society of America; May 7, 2013.
| | | | Guidelines for Prevention and Treatment of Opportunistic Infections among HIV-Exposed and HIV-Infected Children
Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the Infectious Diseases Society of America (IDSA); April 10, 2009. | | | | Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis
Centers for Disease Control and Prevention, December 2007. | | | | Improving the Diagnosis and Treatment of Smear-Negative Pulmonary and Extrapulmonary Tuberculosis among Adults and Adolescents -- Recommendations for HIV-Prevalent and Resource-Constrained Settings
World Health Organization, November 2006. [PDF, 385K] | | | | International Standards for Tuberculosis Care
Tuberculosis Coalition for Technical Assistance, WHO, March 2006. [PDF, 1.9MB] | |
| |
| Policy Reports, Papers, and Briefs | | | Deadly Duo: The Synergy Between HIV/AIDS and Tuberculosis
Center for Global Health Policy, IDSA, HIVMA, June 25, 2009. [PDF, 820K] | | | | Provider-Initiated HIV Testing and Counseling of TB Patients --- Livingstone District, Zambia, September 2004--December 2006
Centers for Disease Control and Prevention. MMWR. 2008;57(11);285-289. | | | | U.S. Policy Options for Strengthening Coordination between Global HIV/AIDS and TB Programs
Phillip Nieburg, Shobana Ramachandran, Kathryn Hofler. Center for Strategic and International Studies (CSIS), February 2008. [PDF, 489K] | | | | Global Tuberculosis Report, 2012
World Health Organization, 2012. [PDF, 3.68MB] | | | | Reported HIV Status of Tuberculosis Patients --- United States, 1993--2005
Centers for Disease Control and Prevention, MMWR 2007;56(42);1103-1106. | | | | Extensively Drug-Resistant Tuberculosis --- United States, 1993--2006
Centers for Disease Control and Prevention, MMWR 2007;56(11):250-253. | | | | Trends in Tuberculosis Incidence--United States, 2006
Centers for Disease Control and Prevention, MMWR 2007;56(11):245-250. | | | | Emergence of Mycobacterium tuberculosis with Extensive Resistance to Second-Line Drugs --- Worldwide, 2000-2004
Centers for Disease Control and Prevention, MMWR 2006;55:301-5. | | | | Development of New Drugs for TB Chemotherapy - Analysis of the Current Drug Pipeline
Médecins Sans Frontières, October 2006. [PDF, 1.2MB] | | | | Tuberculosis Diagnosis and Drug Sensitivity Testing - An Overview of the Current Diagnostic Pipeline
Médecins Sans Frontières, October 2006. [PDF, 390K] | | | | TB/HIV Research Priorities in Resource-Limited Settings
WHO, February 2005. [PDF, 521K] | | | | Fighting TB on the Front Lines: Key Findings and Recommendations on the Crucial Role Played by Front-Line Health Workers in TB Control
Health and Development Networks, the AIDS-Care-Watch Campaign, 2005. [PDF,848K] | | | | Ending Neglect: The Elimination of Tuberculosis in the United States
Institute of Medicine, Committee on the Elimination of Tuberculosis in the United States, Division of Health Promotion and Disease Prevention, June 2000. | |
| |
| Presentations, Interviews, and Roundtable Discussions | | | Grand Rounds: MDR-XDR Tuberculosis
Videos and slides of a symposium at San Francisco General Hospital about MDR-TB and XDR-TB with a focus on South Africa (Tugela Ferry outbreak) and San Francisco. UCSF, October 3, 2007. | |
| |
| Research Summaries | | |
| Online Books and Chapters | | |
| Provider Education and Training | | | Tuberculosis Care with TB-HIV Comanagement: Integrated Management of Adolescent and Adult Illness (IMAI)
Topics covered include how to diagnose TB and TB-HIV coinfection; making treatment decisions; preparing treatment cards; informing the patient and family about TB; preventive
therapy; adherence; supporting the patient during therapy; treatment monitoring; outcome evaluation; special consideration; and infection control. Items on HIV-TB coinfection
are marked in the table of contents with a red ribbon for easy reference. World Health Organization, May 2007. [PDF, 2.57 MB] | | | | HIV Testing and Counseling in TB Clinical Settings Tools
Centers for Disease Control and Prevention, February 2007. | | | | HIV Testing and Counseling in TB Clinical Settings Tools
Centers for Disease Control and Prevention, February 2007. | | | | Management of Tuberculosis in the Context of HIV/AIDS
Pedro Cahn. Cases on the Web, International AIDS Society-USA, May 18, 2004. CME credit expired May 18, 2005. | | | | Management of Latent Tuberculosis Infection in Children and Adolescents: A Guide for the Primary Care Provider
New Jersey Medical School National Tuberculosis Center, 2004. [PDF, 4.4MB] | | | | Guide to the Medical Management of Multidrug-Resistant Tuberculosis
Partners in Health, Harvard Medical School, Brigham and Women's Hospital, 2003. | | | | Guide to the Community-Based Treatment of Multidrug-Resistant Tuberculosis: A DOTS-Plus Handbook
Partners in Health, Harvard Medical School, Bill and Melinda Gates Foundation, 2002. | |
| |
| Slide Sets | | |
| Images | | |
| Program Management Materials | | | Monitoring and Evaluation Toolkit: HIV/AIDS, Tuberculosis and Malaria
WHO, UNAIDS, The Global Fund to Fight AIDS, Tuberculosis & Malaria, USAID, U.S. Department of State, U.S. Department of Health and Human Services, CDC, UNICEF, the
World Bank, June 2004. [PDF, 2.1MB] | |
| |
| Patient and Community Education | | |
| Links | | | CDC National Center for HIV, STD and TB Prevention, Division of Tuberculosis Elimination
Tuberculosis guidelines, surveillance reports, study modules, and more.
| | | | CDC National Prevention Information Network: Tuberculosis Resources
Tuberculosis training and education resource guide, FAQs, and listserv.
| | | | Evidence-Based Tuberculosis Diagnosis
A comprehensive resource for evidence syntheses, policies, guidelines, and research agendas on TB diagnostics | | | | EuroTB
Funded by the European Commission, EuroTB is a WHO collaborating center that conducts surveillance of tuberculosis in all 51 countries of the WHO European Region.
| | | | Francis J. Curry National Tuberculosis Center
Creates, enhances, and disseminates state-of-the-art resources and models of excellence to control and eliminate tuberculosis nationally and internationally. Site features information on provider training, education, and distance learning; surveillance and clinical consultation; and institutional tuberculosis control.
| | | | Global Alliance for TB Drug Development
A nonprofit, public-private partnership whose goal is to accelerate the discovery and development of cost-effective new drugs for tuberculosis.
| | | | The Global Fund to Fight AIDS, Tuberculosis and Malaria
The purpose of the Fund is to attract, manage, and disburse resources through a public-private partnership that will make a sustainable and significant contribution to mitigating the impact caused by HIV/AIDS, tuberculosis, and malaria in countries in need.
| | | | Global Health Reporting: TB
A collection of news items, statistics, reference libraries, and other resources for health journalists, researchers, policymakers, and nongovernmental organizations. A project of the Kaiser Family Foundation. Includes Chinese, French, Hindi, Russian and Spanish versions.
| | | | Global Health Watch
Web site for PBS' "NewsHour With Jim Lehrer" Global Health Unit, which examines efforts to address HIV/AIDS, the increase of HIV/tuberculosis coinfections and the impact of HIV/AIDS on children.
| | | | International Union Against Tuberculosis and Lung Disease
A nonprofit, nongovernmental organization dedicated to the prevention and control of tuberculosis and lung disease in low- and middle-income countries. | | | | Johns Hopkins Center for Tuberculosis Research
Information on epidemiology and natural history, tuberculosis drugs and treatment, and a question-and-answer forum.
| | | | National Institute of Allergy and Infectious Diseases: Tuberculosis Research Activities
NIAID's Division of Microbiology and Infectious Diseases is a leader in research on the basic science, prevention, and treatment of tuberculosis.
| | | | New Jersey Medical School National Tuberculosis Center
Education and training center that conducts state-of-the-art diagnostic, treatment, and prevention programs.
| | | | Stop TB Initiative
Public-private partnership coordinated by the World Health Organization and dedicated to global action to stop tuberculosis.
| | | | World Health Organization TB Page
Information on strategy, operations, monitoring, and evaluation of tuberculosis programs. | |
| |
|
HIV InSite is a project of the UCSF Center for HIV Information. Copyright 2013, Regents of the University of California.